Ruxolitinib-Loaded Imprinted Polymeric Drug Reservoir for the Local Management of Post-Surgical Residual Glioblastoma Cells

(1) Background: The current limitations of glioblastoma (GBM) chemotherapy were addressed by developing a molecularly imprinted polymer (MIP)-based drug reservoir designed for the localized and sustained release of ruxolitinib (RUX) within the tumor post-resection cavity, targeting residual infiltra...

Descripción completa

Detalles Bibliográficos
Autores principales: Bărăian, Alexandra-Iulia, Iacob, Bogdan-Cezar, Sorițău, Olga, Tomuță, Ioan, Tefas, Lucia Ruxandra, Barbu-Tudoran, Lucian, Șușman, Sergiu, Bodoki, Ede
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9962605/
https://www.ncbi.nlm.nih.gov/pubmed/36850247
http://dx.doi.org/10.3390/polym15040965

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9962605/
https://www.ncbi.nlm.nih.gov/pubmed/36850247
http://dx.doi.org/10.3390/polym15040965

Ejemplares similares